vimarsana.com

Page 62 - பல்கலைக்கழகம் ஆஃப் சிகாகோ மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Illinois Coronavirus Updates: New Vaccination Sites, Chicago Reopening Lakefront

Chicago Prioritizes COVID Vaccine Access for Homeless, Those in Congregant Living Settings City health officials are working to ensure equitable access to the coronavirus vaccine, and part of that strategy is to prioritize vaccinations for homeless Chicagoans. “I’m so pleased to be receiving my second dose of the COVID vaccine,” Constance Foster, a resident at the Pacific Garden Mission in Chicago, said. Foster was one of 170 residents and staff at the mission who received their second doses of the vaccine on Tuesday, part of the city’s effort to ensure that those individuals who live and work in congregant settings can get access to the treatment as soon as possible.

Nurses at Harvey s Ingalls Hospital ratify first-ever contract, provides wage increases

New Uterine Fibroid Treatment Shows Promise

iStock There s good news for women of reproductive age who are coping with the debilitating side effects of uterine fibroids, the benign growths on the uterus that can cause massive bleeding, pain, anemia, painful sex, miscarriage, or infertility. A study published February 18, 2021, in the  New England Journal of Medicine has found that a daily combination oral therapy of 40 milligrams (mg) of the drug relugolix (Relugolix-CT) with small doses of synthetic estrogen (1 mg estradiol) and synthetic progesterone (.5 mg norethindrone acetate) led to dramatic improvement in symptoms and, to a lesser degree, shrinkage of the uterine fibroids themselves. The therapy, which is given as one pill, is currently under review by the U.S. Food and Drug Administration (FDA), with approval anticipated for this summer (mid-2021).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.